Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 755 views
134 Publications
Volume 4 - 2025
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 465 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 785 views
Original Research
Published on 27 Feb 2025
FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
- 618 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 647 views
Mini Review
Published on 26 Feb 2025
The role of glucocorticoids in erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1540152
- 1,009 views
Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
- 432 views
Mini Review
Published on 07 Feb 2025
The aging hematopoietic stem cell niche: a mini review
Frontiers in Hematology
doi 10.3389/frhem.2025.1525132
- 1,319 views
Editorial
Published on 24 Jan 2025
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
Frontiers in Hematology
doi 10.3389/frhem.2025.1548984
- 696 views
Volume 3 - 2024
Original Research
Published on 21 Jan 2025
Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study
Frontiers in Hematology
doi 10.3389/frhem.2024.1502166
- 2,287 views
- 1 citation
Case Report
Published on 16 Jan 2025
Case report: VEXAS syndrome: first documented cases in Latin America
Frontiers in Hematology
doi 10.3389/frhem.2024.1501337
- 530 views
Case Report
Published on 10 Jan 2025
Case report: A decade-long journey with cyclic thrombocytopenia
Frontiers in Hematology
doi 10.3389/frhem.2024.1482891
- 595 views
Original Research
Published on 26 Dec 2024
Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology
Frontiers in Hematology
doi 10.3389/frhem.2024.1469176
- 830 views
- 1 citation
Mini Review
Published on 24 Dec 2024
Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms
Frontiers in Hematology
doi 10.3389/frhem.2024.1504327
- 795 views
Case Report
Published on 17 Dec 2024
A patient with concurrent EBV-negative diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: a case report
Frontiers in Hematology
doi 10.3389/frhem.2024.1463487
- 640 views
Case Report
Published on 12 Dec 2024
Ruxolitinib and pegylated interferon in Chronic Neutrophilic Leukemia due to a pathogenic CSF3R germline variant: a case report
Frontiers in Hematology
doi 10.3389/frhem.2024.1508463
- 402 views